Literature DB >> 17074851

Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.

C M Salvatore1, M Fonseca-Aten, K Katz-Gaynor, A M Gomez, A Mejias, C Somers, S Chavez-Bueno, G H McCracken, R D Hardy.   

Abstract

Mycoplasma pneumoniae is a leading cause of pneumonia and is associated with asthma. Evidence links M. pneumoniae respiratory disease severity with interleukin-12 (IL-12) concentration in respiratory secretions. We evaluated the microbiologic, inflammatory, and pulmonary function indices of M. pneumoniae pneumonia in IL-12 (p35) knockout (KO) mice and wild-type (WT) mice to determine the role of IL-12 in M. pneumoniae respiratory disease. Eight-week-old wild-type BALB/c mice and 8-week-old IL-12 (p35) KO BALB/c mice were inoculated once intranasally with 10(7) CFU of M. pneumoniae. Mice were evaluated at days 2, 4, and 7 after inoculation. Outcome variables included quantitative bronchoalveolar lavage (BAL) M. pneumoniae culture, lung histopathologic scores (HPS), BAL cytokine concentrations determined by enzyme-linked immunosorbent assay (tumor necrosis factor alpha [TNF-alpha], gamma interferon [IFN-gamma], IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-10, and granulocyte-macrophage colony-stimulating factor) and plethysmography, before and after methacholine, to assess airway obstruction (AO) and airway hyperreactivity (AHR). IL-12 (p35) KO mice infected with M. pneumoniae were found to have significantly lower BAL M. pneumoniae concentrations compared with M. pneumoniae-infected WT mice. Lung HPS and the parenchymal pneumonia subscores (neutrophilic alveolar infiltrate), as well as AO, were significantly lower in infected KO mice. No difference was found for AHR. Infected KO mice had significantly lower BAL concentrations of IFN-gamma than WT mice; a trend toward lower BAL concentrations was observed for IL-10 (P = 0.065) and TNF-alpha (P = 0.078). No differences were found for IL-1beta, IL-2, IL-4, IL-5, or IL-6. The lack of IL-12 in experimental M. pneumoniae pneumonia was associated with less severe pulmonary disease and more rapid microbiologic and histologic resolution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074851      PMCID: PMC1828434          DOI: 10.1128/IAI.01249-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms.

Authors:  Y Zhan; Z Liu; C Cheers
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)-deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor.

Authors:  C Wu; J Ferrante; M K Gately; J Magram
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

3.  Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.

Authors:  J Schwarze; E Hamelmann; K L Bradley; K Takeda; E W Gelfand
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  Respiratory syncytial virus affects pulmonary function in BALB/c mice.

Authors:  S M van Schaik; G Enhorning; I Vargas; R C Welliver
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

5.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography.

Authors:  E Hamelmann; J Schwarze; K Takeda; A Oshiba; G L Larsen; C G Irvin; E W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

6.  IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.

Authors:  A R Satoskar; S Rodig; S R Telford; A A Satoskar; S K Ghosh; F von Lichtenberg; J R David
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

7.  IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells.

Authors:  K Kawakami; Y Koguchi; M H Qureshi; A Miyazato; S Yara; Y Kinjo; Y Iwakura; K Takeda; S Akira; M Kurimoto; A Saito
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

8.  Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells.

Authors:  T Zhang; K Kawakami; M H Qureshi; H Okamura; M Kurimoto; A Saito
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

9.  Interleukin-12 is indispensable for protective immunity against Leishmania major.

Authors:  F Mattner; K Di Padova; G Alber
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

10.  Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.

Authors:  A M Cooper; J Magram; J Ferrante; I M Orme
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  17 in total

1.  Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.

Authors:  Chonnamet Techasaensiri; Claudia Tagliabue; Marianna Cagle; Pooya Iranpour; Kathy Katz; Thirumalai R Kannan; Jacqueline J Coalson; Joel B Baseman; R Doug Hardy
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Mycoplasma pneumoniae-derived lipopeptides induce acute inflammatory responses in the lungs of mice.

Authors:  Takashi Shimizu; Yutaka Kida; Koichi Kuwano
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

4.  Mycoplasma pneumoniae extract induces an IL-17-associated inflammatory reaction in murine lung: implication for mycoplasmal pneumonia.

Authors:  Daisuke Kurai; Kazuhide Nakagaki; Hiroo Wada; Takeshi Saraya; Shigeru Kamiya; Yasunori Fujioka; Koh Nakata; Hajime Takizawa; Hajime Goto
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

5.  Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia.

Authors:  C M Salvatore; M Fonseca-Aten; K Katz-Gaynor; A M Gomez; R D Hardy
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

6.  Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.

Authors:  C M Salvatore; C Techasaensiri; C Tagliabue; K Katz; N Leos; A M Gomez; G H McCracken; R D Hardy
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

7.  The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.

Authors:  C Tagliabue; C M Salvatore; C Techasaensiri; A Mejias; J P Torres; K Katz; A M Gomez; S Esposito; N Principi; R D Hardy
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

8.  Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.

Authors:  Matthew D Woolard; Lucinda L Hensley; Thomas H Kawula; Jeffrey A Frelinger
Journal:  Infect Immun       Date:  2008-04-07       Impact factor: 3.441

9.  Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae.

Authors:  Jen-Feng Lai; Carlene L Zindl; Lynn B Duffy; T Prescott Atkinson; Yong Woo Jung; Nico van Rooijen; Ken B Waites; Duncan C Krause; David D Chaplin
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

10.  Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.

Authors:  R Doug Hardy; Jacqueline J Coalson; Jay Peters; Adriana Chaparro; Chonnamet Techasaensiri; Angelene M Cantwell; T R Kannan; Joel B Baseman; Peter H Dube
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.